microdosing glp 1 Exploring GLP-1 Medications: Benefits Beyond Weight Loss Noom Launches Microdose GLP-1 Program,

First introduced in 1927, insulin shock therapy was devised by Manfred Sakel, an Austrian neuropsychologist, after he observed an improvement in the psychiatric condition of one of his patients with a morphine addiction when he recovered from a hypoglycaemic coma accidentally induced by too much insulin

This is why we have a rule of being NPO ( nil per os in Latin, meaning nothing to eat or drink) from midnight the night before

As the burden of diabetes continues to grow across Africa, the future of care lies in helping people live healthier for longer, not simply managing disease

doi: 10.1007/s40620-020-00738-9 [DOI] [PMC free article] [PubMed] [Google Scholar] 100.Bendotti G, Montefusco L, Lunati ME, et al

GLP-1 weight-loss drugs will still be cheap with Medicare, but there's a catch Medicare has delayed a program for older Americans that would've required participating insurance companies to cover GLP-1 weight loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound

"They are a phenomenon," Eric Tichy, lead author of the ASHP report and a division chair of supply chain management at Mayo Clinic, said of the public's demand for GLP-1 drugs